Intravesical chemotherapy in a controlled trial with thio-tepa versus doxorubicin hydrochloride

Y. Horn, A. Eidelman, N. Walach, M. Ilian

Research output: Contribution to journalArticlepeer-review

Abstract

We treated 25 patients with recurrent transitional cell carcinoma of the bladder with intravesical chemotherapy. The 2 drugs used were doxorubicin hydrochloride and thio-tepa introduced at 3-week intervals and checked for efficacy by repeated cystoscopy after every 3 instillations. The clinical data and results of both groups are presented, and the importance of intravesical treatment with minimal toxicity in this relatively benign condition is discussed.

Original languageEnglish
Pages (from-to)652-654
Number of pages3
JournalJournal of Urology
Volume125
Issue number5
DOIs
StatePublished - 1981

Fingerprint

Dive into the research topics of 'Intravesical chemotherapy in a controlled trial with thio-tepa versus doxorubicin hydrochloride'. Together they form a unique fingerprint.

Cite this